Role of smooth muscle cell p53 in pulmonary arterial hypertension.
Animals
Apoptosis
/ genetics
Blotting, Western
Cells, Cultured
Cellular Senescence
/ genetics
DNA Repair
/ genetics
Echocardiography
Humans
Hypertension, Pulmonary
/ genetics
Hypoxia
/ metabolism
Male
Metabolomics
/ methods
Mice
Mice, Inbred C57BL
Myocytes, Smooth Muscle
/ metabolism
RNA, Small Interfering
/ genetics
Tumor Suppressor Protein p53
/ genetics
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
11
2018
accepted:
11
02
2019
entrez:
27
2
2019
pubmed:
27
2
2019
medline:
26
11
2019
Statut:
epublish
Résumé
Pulmonary arterial hypertension (PAH) is characterized by remodeling and narrowing of the pulmonary arteries, which lead to elevation of right ventricular pressure, heart failure, and death. Proliferation of pulmonary artery smooth muscle cells (PASMCs) is thought to be central to the pathogenesis of PAH, although the underlying mechanisms are still being explored. The protein p53 is involved in cell cycle coordination, DNA repair, apoptosis, and cellular senescence, but its role in pulmonary hypertension (PH) is not fully known. We developed a mouse model of hypoxia-induced pulmonary hypertension (PH) and found significant reduction of p53 expression in the lungs. Our in vitro experiments with metabolomic analyses and the Seahorse XF extracellular flux analyzer indicated that suppression of p53 expression in PASMCs led to upregulation of glycolysis and downregulation of mitochondrial respiration, suggesting a proliferative phenotype resembling that of cancer cells. It was previously shown that systemic genetic depletion of p53 in a murine PH model led to more severe lung manifestations. Lack of information about the role of cell-specific p53 signaling promoted us to investigate it in our mouse PH model with the inducible Cre-loxP system. We generated a mouse model with SMC-specific gain or loss of p53 function by crossing Myh11-Cre/ERT2 mice with floxed Mdm4 mice or floxed Trp53 mice. After these animals were exposed to hypoxia for 4 weeks, we conducted hemodynamic and echocardiographic studies. Surprisingly, the severity of PH was similar in both groups of mice and there were no differences between the genotypes. Our findings in these mice indicate that activation or suppression of p53 signaling in SMCs has a minor role in the pathogenesis of PH and suggest that p53 signaling in other cells (endothelial cells, immune cells, or fibroblasts) may be involved in the progression of this condition.
Identifiants
pubmed: 30807606
doi: 10.1371/journal.pone.0212889
pii: PONE-D-18-32948
pmc: PMC6391010
doi:
Substances chimiques
RNA, Small Interfering
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0212889Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H944-H957
pubmed: 27591215
Nature. 2007 Mar 22;446(7134):444-8
pubmed: 17334357
Cell Metab. 2013 Oct 1;18(4):491-504
pubmed: 24093674
Nat Med. 2016 Jan;22(1):78-83
pubmed: 26657143
Cell Physiol Biochem. 2017;42(4):1603-1613
pubmed: 28738389
Circ Res. 2014 Jun 20;115(1):148-64
pubmed: 24951764
BMJ. 2018 Mar 14;360:j5492
pubmed: 29540357
Cell Metab. 2014 Dec 2;20(6):967-77
pubmed: 25456739
Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L753-61
pubmed: 21335523
Cell Metab. 2012 Jan 4;15(1):51-64
pubmed: 22225876
Cell Rep. 2014 Jun 12;7(5):1691-1703
pubmed: 24857662
Mol Cell Biol. 2006 Jan;26(1):192-8
pubmed: 16354690
Cell. 2017 Mar 23;169(1):132-147.e16
pubmed: 28340339
Aging Cell. 2016 Oct;15(5):973-7
pubmed: 26864908
N Engl J Med. 2015 Aug 27;373(9):834-44
pubmed: 26308684
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Cell Metab. 2014 Apr 1;19(4):558-73
pubmed: 24508506
J Clin Invest. 2013 Mar;123(3):966-72
pubmed: 23454759
Nature. 1992 Jul 2;358(6381):15-6
pubmed: 1614522
N Engl J Med. 2013 Jul 25;369(4):330-40
pubmed: 23883378
J Mol Cell Cardiol. 2015 Aug;85:183-98
pubmed: 26055447
Circulation. 2010 May 11;121(18):2045-66
pubmed: 20458021
Cancer Res. 2009 Jun 1;69(11):4918-25
pubmed: 19458066